![Juliane Gassert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Juliane Gassert first degree
Entity | Entity type | Industry | |
---|---|---|---|
EMBL Ventures GmbH
![]() EMBL Ventures GmbH Investment ManagersFinance EMBL Ventures GmbH (EMBL Ventures) is a venture investment arm of EMBL which was founded in 2001 by Drs. Stefan Herr, Christoph Antz and Jan Adams to provide start-up companies exploiting EMBL research and intellectual property with equity and expertise to build up and expand their business. Headquartered in Heidelberg, EMBL Ventures manages funds on behalf of institutional and private investors, forming a triad with EMBL (European Molecular Biology Laboratory) and EMBLEM (EMBL Enterprise Management Technology Transfer GmbH) to provide exclusive access to unique technology commercialization opportunities from the EMBL. In addition, their investment activities complement and exploit synergies with EMBL and EMBLEM, providing financial and strategic investors with access to an attractive private equity market and an international scientific and research community, respectively.
5
| Subsidiary | Investment Managers | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Juliane Gassert via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Sloning Bio Technology GmbH
![]() Sloning Bio Technology GmbH Miscellaneous Commercial ServicesCommercial Services Sloning BioTechnology specializes in the production of highly genetically diverse and precise customized libraries. The company offers high quality, innovative, tailored protein engineering solutions to its industrial and biopharmaceutical customers worldwide. As a business specializing in the development and production of genetically diverse libraries, Sloning BioTechnology GmbH offers high quality, innovative, tailored protein engineering solutions to its industrial and biopharmaceutical customers worldwide. The firm's Slonomics core technology is a unique DNA engineering platform that uses defined sets of double stranded DNA triplets to precisely introduce the required mutations into any DNA sequence. This multiply validated technology takes a novel approach to enable the realization of highly complex design concepts while at the same time ensuring that libraries generated by Sloning have the very highest standards of reliability. It harnesses the capabilities of Slonomics to synthesize SlonoMax and SlonoMax libraries are customized mutant libraries that significantly improve the efficiency of screening for new and improved proteins for therapeutic, enzymatic or technical applications. In addition, it offers a premium gene synthesis service using Slonomics for its industrial clients. SlonoGene is a tailored service offering gene customization and optimization suited perfectly to the needs of its customers. | Miscellaneous Commercial Services | Chief Executive Officer | |
Curetis GmbH
![]() Curetis GmbH Medical SpecialtiesHealth Technology Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany. | Medical Specialties | Chairman | |
CURETIS N.V. | Medical/Nursing Services | Director/Board Member | |
Steinbeis Europa Zentrum | Corporate Officer/Principal | ||
AFFIMED N.V. | Biotechnology | Director/Board Member | |
CONFORMIS, INC. | Medical Specialties | Director/Board Member | |
MITSUBISHI RESEARCH INSTITUTE, INC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Boehringer Ingelheim GmbH
![]() Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Calibrium Private Investments GmbH
![]() Calibrium Private Investments GmbH Investment ManagersFinance Calibrium Private Investments GmbH (formerly Aeris Capital AG) is a venture capital firm with headquarters in Zurich, Switzerland. The firm was founded in 2006. | Investment Managers | Private Equity Investor | |
University of Regensburg | College/University | Undergraduate Degree | |
Affimed NV Niederlassung Deutschland
![]() Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Universität Stuttgart | College/University | Doctorate Degree | |
Barnev, Inc.
![]() Barnev, Inc. Information Technology ServicesTechnology Services Barnev, Inc. is a healthcare information technology company specializing in the development, manufacturing, and marketing of comprehensive monitoring and information solutions to clinicians and hospitals for labor and delivery. The firm is the first to market with delivery suite/product solutions that improve the clinical management of patients, and improve economic efficiency for its customers. Its first product, the BirthTrack™ Continuous Labor Monitoring System, is the most exciting innovation in labor progression monitoring since the Friedman Labor Curve was introduced over 50 years ago. The BirthTrack System is a revolutionary continuous labor monitoring technology that provides obstetric caregivers invaluable, precise, objective, real-time information about the physical progress of labor. | Information Technology Services | Director/Board Member | |
ViraTherapeutics GmbH
![]() ViraTherapeutics GmbH BiotechnologyHealth Technology ViraTherapeutics GmbH is a biopharmaceutical company that develops virus-based immunotherapeutics for cancer treatment. It specializes in the development of oncolytic cancer vaccines based on Vesicular Stomatitis Virus Glycoprotein G (VSV-GP). The company was founded by Dorothee Holm-von Laer in 2013 and is headquartered in Innsbruck, Austria. | Biotechnology | Chief Executive Officer | |
LanthioPep BV
![]() LanthioPep BV Medical SpecialtiesHealth Technology LanthioPep BV specializes in vivo stability of therapeutic and diagnostic imaging peptides. Its products include pancyte, lanthi apelin and galanin agonist. The company is headquartered in Groningen, the Netherlands. | Medical Specialties | Chief Executive Officer | |
Lanthio Pharma BV
![]() Lanthio Pharma BV Medical SpecialtiesHealth Technology Lanthio Pharma BV focuses on discovering and developing lantipeptides for the generation of novel peptide therapeutics. Its product is a lanthionine-stabilized specific agonist of the AT2 receptor, which has great potential in diseases where tissue protection is important, like fibrosis. The company was founded in 2010 and is headquartered in Groningen, the Netherlands. | Medical Specialties | Chief Executive Officer | |
Dana-Farber Cancer Institute, Inc.
![]() Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Henley Management College | College/University | Masters Business Admin | |
Sensovation AG
![]() Sensovation AG Electronic Equipment/InstrumentsElectronic Technology Sensovation AG manufactures and supplies scientific imaging instrumentation products. The firm specializes in the development and production of scientific imaging and low light detection solutions, based on charge coupled device and complementary metal oxide semiconductor technologies. It offers automated digital microscopes, microarray analyzers, and scientific cameras for bioimaging, diagnostics, and quality control in clean technology applications. It also engages in partnerships focused on building and supplying commercial production systems and platforms. The company was founded by Stefan Bickert and Paul Hing in 2000 and is headquartered in Radolfzell, Germany. | Electronic Equipment/Instruments | Chairman |
Statistics
International
Germany | 12 |
United States | 5 |
Switzerland | 3 |
Netherlands | 3 |
Japan | 2 |
Sectoral
Health Technology | 11 |
Consumer Services | 4 |
Commercial Services | 3 |
Health Services | 3 |
Finance | 3 |
Operational
Director/Board Member | 8 |
Chief Executive Officer | 4 |
Corporate Officer/Principal | 4 |
Private Equity Investor | 4 |
Private Equity Analyst | 3 |
Most connected contacts
Insiders | |
---|---|
Frank Mühlenbeck | 16 |
Heinz Schwer | 8 |
Sebastian Schefzyk | 1 |
Caroline Sauer | 1 |
Cornelia Brosi | 1 |
- Stock Market
- Insiders
- Juliane Gassert
- Company connections